Cilcare Sas
Clinical trials sponsored by Cilcare Sas, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could hearing problems be an early sign of brain disease? Results expected Dec 2026 (estimated)
- Ear injection aims to repair Diabetes-Linked hearing damage Results expected Jul 2027 (estimated)
-
A single shot into the ear: can a new drug quiet constant ringing?
Symptom relief Not yet recruitingResearchers are testing whether a one-time injection of an experimental drug called paliroden into the middle ear is safe and can help adults with chronic, constant tinnitus in both ears. Participants, ages 18 to 75, have normal hearing thresholds but struggle to understand speec…
Phase 1/2 • Sponsor: Cilcare SAS • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Ear injection aims to repair Diabetes-Linked hearing damage
Symptom relief Not yet recruitingThis study tests a single injection of CIL001 (Paliroden) into the ear to repair nerve damage that causes hearing problems in people with type 2 diabetes. The trial includes 135 adults aged 45-75 with diabetes for at least 5 years. Researchers will check safety and whether the in…
Phase 1/2 • Sponsor: Cilcare SAS • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC